Sign Up to like & get
recommendations!
0
Published in 2025 at "Nature Communications"
DOI: 10.1038/s41467-025-61688-z
Abstract: Lipid nanoparticles (LNPs) are a promising platform for mRNA delivery. However, their use in inflammatory pulmonary diseases is limited by reactogenicity and suboptimal delivery. Here we develop a non-inflammatory LNP (NIF-LNP) by incorporating ursolic acid,…
read more here.
Keywords:
activating non;
lung;
atpase activating;
delivery ... See more keywords